新多病共存指数预测缺血性卒中功能结局
研究基于脑卒中监测项目前瞻性队列,开发并内部验证预测缺血性卒中后90天功能结局的新多病共存指数。该指数纳入卒中前mRS、年龄、充血性心衰、体重减轻、糖尿病、其他神经疾病及协同交互项,在验证集中解释31%功能结局变异,校准良好(p=0.41),预测不良功能结局的AUC为0.81,优于改良Charlson合并症指数。
要点
- 新多病共存指数可预测缺血性卒中后90天不良功能结局,AUC为0.81。
- 指数纳入卒中前mRS、年龄、心衰、体重减轻、糖尿病等预测因子。
- 识别出痴呆×年龄、心衰×肾衰、卒中前mRS×既往卒中/TIA的协同交互。
核心结论
- 新多病共存指数经内部验证可改善缺血性卒中后90天功能结局的预测。
研究设计与样本
- 前瞻性队列研究,纳入2008-2017年Corpus Christi脑卒中监测项目中缺血性卒中患者,基线及90天访谈。
- 功能结局评分基于平均22项ADL/IADL条目(范围1-4),评分>3定义为不良功能结局。
- 采用机器学习技术选择并加权共病及卒中前损伤,开发新指数并进行内部验证。
主要发现
- 验证数据集中,指数单独解释功能结局评分31%的变异。
- 指数校准良好(p=0.41),预测不良功能结局的AUC为0.81。
- 指数在预测功能结局评分和卒中后mRS方面优于改良Charlson合并症指数。
关键数值与推荐
- 功能结局评分>3(ADL/IADL很多困难)视为不良功能结局。
- 重要预测因子包括卒中前mRS、年龄、充血性心衰、体重减轻、糖尿病、其他神经疾病。
- 协同交互项包括痴呆×年龄、心衰×肾衰竭、卒中前mRS×既往卒中/TIA。
临床怎么用
- 该指数可用于缺血性卒中患者90天功能结局的风险分层,辅助临床决策。
- 指数优于改良Charlson合并症指数,可替代其用于卒中后功能结局预测。
局限性
- 研究为内部验证,需外部人群验证其泛化性。
- 证据等级为Class II,提示预测效能需进一步确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether a new index for multiple chronic conditions (MCCs) predicts poststroke functional outcome (FO), we developed and internally validated the new MCC index in patients with ischemic stroke. METHODS: A prospective cohort of patients with ischemic stroke (2008-2017) was interviewed at baseline and 90 days in the Brain Attack Surveillance in Corpus Christi Project. An average of 22 activities of daily living (ADL)/instrumental ADL (IADL) items measured the FO score (range 1-4) at 90 days. A FO score >3 (representing a lot of difficulty with ADL/IADLs) was considered unfavorable FO. A new index was developed using machine learning techniques to select and weight conditions and prestroke impairments. RESULTS: Prestroke modified Rankin Scale (mRS) score, age, congestive heart failure (CHF), weight loss, diabetes, other neurologic disorders, and synergistic effects (dementia × age, CHF × renal failure, and prestroke mRS × prior stroke/TIA) were identified as important predictors in the MCC index. In the validation dataset, the index alone explained 31% of the variability in the FO score, was well-calibrated (p = 0.41), predicted unfavorable FO well (area under the receiver operating characteristic curve 0.81), and outperformed the modified Charlson Comorbidity Index in predicting the FO score and poststroke mRS. CONCLUSIONS: A new MCC index was developed and internally validated to improve the prediction of poststroke FO. Novel predictors and synergistic interactions were identified. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that in patients with ischemic stroke, an index for MCC predicts FO at 90 days.
引用
- Jiang X, Wang L, Morgenstern LB, et al. New Index for Multiple Chronic Conditions Predicts Functional Outcome in Ischemic Stroke. Neurology. 2020. PMID: 33024024. doi:10.1212/WNL.0000000000010992
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。